1. Home
  2. AGRO vs RARE Comparison

AGRO vs RARE Comparison

Compare AGRO & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adecoagro S.A.

AGRO

Adecoagro S.A.

SELL

Current Price

$10.54

Market Cap

1.6B

ML Signal

SELL

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

SELL

Current Price

$14.92

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AGRO
RARE
Founded
2002
2010
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
AGRO
RARE
Price
$10.54
$14.92
Analyst Decision
Hold
Buy
Analyst Count
8
20
Target Price
$13.40
★ $26.79
AVG Volume (30 Days)
532.3K
★ 5.1M
Earning Date
11-12-2026
11-03-2026
Dividend Yield
★ 3.40%
N/A
EPS Growth
N/A
★ 7.31
EPS
★ N/A
N/A
Revenue
N/A
★ $673,000,000.00
Revenue This Year
$56.84
$13.42
Revenue Next Year
N/A
$31.52
P/E Ratio
$37.52
★ N/A
Revenue Growth
N/A
★ 20.13
52 Week Low
$6.89
$12.73
52 Week High
$15.89
$39.89

Technical Indicators

Market Signals
Indicator
AGRO
RARE
Relative Strength Index (RSI) 45.35 39.77
Support Level $9.82 $13.95
Resistance Level $10.91 $15.81
Average True Range (ATR) 0.35 0.68
MACD -0.02 0.45
Stochastic Oscillator 52.02 52.42

Price Performance

Historical Comparison
AGRO
RARE

About AGRO Adecoagro S.A.

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: